Compounds > argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-
Page last updated: 2024-09-03

argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)- and Malignant Hypertension

argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)- has been researched along with Malignant Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fejes-Tóth, G; Filep, J; Frölich, JC2

Other Studies

2 other study(ies) available for argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)- and Malignant Hypertension

ArticleYear
Effect of vasopressin blockade on blood pressure in conscious rats with malignant two-kidney Goldblatt hypertension.
    Clinical and experimental hypertension. Part A, Theory and practice, 1985, Volume: 7, Issue:7

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Female; Hypertension, Malignant; Hypertension, Renovascular; Rats; Vasopressins

1985
Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Clinical and experimental hypertension. Part A, Theory and practice, 1985, Volume: 7, Issue:10

    Topics: Animals; Arginine Vasopressin; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Hypertension, Malignant; Rats; Sodium Chloride; Vasopressins

1985